These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1384 related items for PubMed ID: 18070147

  • 21. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.
    Cancer Res; 2003 Aug 01; 63(15):4561-7. PubMed ID: 12907632
    [Abstract] [Full Text] [Related]

  • 22. BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas.
    Lee JH, Lee ES, Kim YS, Won NH, Chae YS.
    Pathology; 2006 Jun 01; 38(3):201-4. PubMed ID: 16753739
    [Abstract] [Full Text] [Related]

  • 23. BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy.
    Santoro A, Pannone G, Carosi MA, Francesconi A, Pescarmona E, Russo GM, Feola A, Losito S, Franco R, Nappi L, Aquino G, De Rosa G, Di Domenico M, Bufo P.
    J Cell Biochem; 2013 May 01; 114(5):1174-82. PubMed ID: 23192464
    [Abstract] [Full Text] [Related]

  • 24. [Expression of BRAF V600E mutation in different thyroid lesions].
    Wang W, Li XH, Zhang YH, Li J, Chen J, Zhao P, Li QY, Xiang JJ, Li X, Xu RJ.
    Zhonghua Zhong Liu Za Zhi; 2011 May 01; 33(5):354-7. PubMed ID: 21875464
    [Abstract] [Full Text] [Related]

  • 25. Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis.
    Nechifor-Boilă A, Decaussin-Petrucci M, Gazzo S, Paşcanu I, Borda A.
    Rom J Morphol Embryol; 2012 May 01; 53(2):263-7. PubMed ID: 22732794
    [Abstract] [Full Text] [Related]

  • 26. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.
    Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C.
    Cancer; 2007 Sep 15; 110(6):1218-26. PubMed ID: 17685465
    [Abstract] [Full Text] [Related]

  • 27. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L, Shindo M, Schuff K, Corless C.
    Arch Otolaryngol Head Neck Surg; 2012 Jan 15; 138(1):44-9. PubMed ID: 22249628
    [Abstract] [Full Text] [Related]

  • 28. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
    Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M.
    Hum Pathol; 2005 Jun 15; 36(6):694-7. PubMed ID: 16021577
    [Abstract] [Full Text] [Related]

  • 29. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.
    Goutas N, Vlachodimitropoulos D, Bouka M, Lazaris AC, Nasioulas G, Gazouli M.
    Anticancer Res; 2008 Jun 15; 28(1A):305-8. PubMed ID: 18383861
    [Abstract] [Full Text] [Related]

  • 30. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM, Huang YW, Huang JS, Wang CH, Kok VC, Hung CM, Chen HM, Tzen CY.
    Ann Surg Oncol; 2007 Oct 15; 14(10):3011-8. PubMed ID: 17638058
    [Abstract] [Full Text] [Related]

  • 31. Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
    Kim MH, Bae JS, Lim DJ, Lee H, Jeon SR, Park GS, Jung CK.
    Endocr Relat Cancer; 2014 Oct 15; 21(6):891-902. PubMed ID: 25266729
    [Abstract] [Full Text] [Related]

  • 32. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov 15; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 33. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma.
    Gu LQ, Li FY, Zhao L, Liu Y, Zang XX, Wang TX, Chen HP, Ning G, Zhao YJ.
    Thyroid; 2009 Apr 15; 19(4):347-54. PubMed ID: 19355825
    [Abstract] [Full Text] [Related]

  • 34. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
    Cavaco BM, Batista PF, Martins C, Banito A, do Rosário F, Limbert E, Sobrinho LG, Leite V.
    Endocr Relat Cancer; 2008 Mar 15; 15(1):207-15. PubMed ID: 18310288
    [Abstract] [Full Text] [Related]

  • 35. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
    Bastos AU, Oler G, Nozima BH, Moysés RA, Cerutti JM.
    Eur J Endocrinol; 2015 Oct 15; 173(4):525-40. PubMed ID: 26338373
    [Abstract] [Full Text] [Related]

  • 36. The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
    Walczyk A, Kowalska A, Kowalik A, Sygut J, Wypiórkiewicz E, Chodurska R, Pięciak L, Góźdź S.
    Clin Endocrinol (Oxf); 2014 Jun 15; 80(6):899-904. PubMed ID: 24354346
    [Abstract] [Full Text] [Related]

  • 37. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
    Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nosé V.
    Am J Surg Pathol; 2007 Sep 15; 31(9):1337-43. PubMed ID: 17721188
    [Abstract] [Full Text] [Related]

  • 38. Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.
    Howell GM, Carty SE, Armstrong MJ, Lebeau SO, Hodak SP, Coyne C, Stang MT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L.
    Ann Surg Oncol; 2011 Dec 15; 18(13):3566-71. PubMed ID: 21594703
    [Abstract] [Full Text] [Related]

  • 39. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.
    Muzza M, Degl'Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L.
    Clin Endocrinol (Oxf); 2010 May 15; 72(5):702-8. PubMed ID: 20447069
    [Abstract] [Full Text] [Related]

  • 40. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.
    Onder S, Ozturk Sari S, Yegen G, Sormaz IC, Yilmaz I, Poyrazoglu S, Sanlı Y, Giles Senyurek Y, Kapran Y, Mete O.
    Endocr Pathol; 2016 Jun 15; 27(2):153-61. PubMed ID: 26951110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 70.